key: cord-0740823-j54vpbhi
authors: Bogere, Naghib; Bongomin, Felix; Katende, Andrew; Ssebambulidde, Kenneth; Ssengooba, Willy; Ssenfuka, Henry; Kigozi, Edgar; Biraro, Samuel; Kateete, David P; Andia-Biraro, Irene
title: Performance and Cost-Effectiveness of a Pooled-Testing Strategy for SARS-CoV-2 Using Real-Time Polymerase Chain Reaction in Uganda
date: 2021-10-28
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2021.10.038
sha: 2f1d34a4c91d642a23d2b1ca163bed90afa4eaef
doc_id: 740823
cord_uid: j54vpbhi

Real-time polymerase chain reaction (RT-PCR) remains the gold standard for detection of SARS CoV-2. We assessed the performance of a pooled-testing strategy on RT-PCR and its cost-effectiveness. A total of 1,280 left-over respiratory samples collected between 19th April and 6th May 2021 were tested in 128 pools of 10 samples each, out of which 16 pools were positive. The positivity rate of the unpooled samples was 1.9% (24/1280). After parallel testing using the individual and pooled sample testing strategies, positive agreement was 100% and negative agreement was 99.8%. The overall median cycle threshold (Ct) value of the unpooled samples was 29.8 (interquartile range: 22.3 — 34.3). Pools that remained positive had lower median Ct values compared to those that turned out negative (28.8 versus 34.8, p=0.0.035). Pooled testing reduced cost by over 4-fold. Pooled testing strategy may be a more cost-effective approach to diagnose SARS-CoV-2 in resource-limited setting without compromising diagnostic performance.

. 115 The probability of agreement was 99.8% and the Cohen's kappa statistic was 0.932. 116 The overall median cycle threshold (Ct) value of the unpooled samples was 29. The average cost-effectiveness ratio was 4-fold lower using pooled testing compared 120 to individual sample testing strategy (12.6 USD per test versus 56 USD per test, 121 respectively) (Figure 1) . The total cost for testing the samples using pooled testing 122 was 77.5% less than individual testing (16,128 USD versus 71,680 USD 123 respectively). The incremental cost effectiveness ratio (iCER) was 55,552 USD for a 124 further detection of 3 tests using the individual testing method.

In this study to assess the diagnostic performance and cost-effectiveness of the 127 pooled testing strategy using the RT-PCR platform, we report two main findings. 

Cost effectiveness of sample pooling 195 to test for SARS-CoV-2

RT-qPCR testing capacity by sample pooling

Lessons from 202 applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests

Upper Respiratory Specimens Using a SARS-CoV-2 Real-time RT-PCR Assay 206

Authorized for Emergency Use in Low-Prevalence Populations for High-Throughput

Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 210 surveillance in the general population (CoV-Surv Study): a structured summary of a 211 study protocol for a cluster-randomised, two-factorial controlled trial

Effectiveness of Sample Pooling Strategies for SARS-CoV-2 Mass 214

Screening by RT-PCR: A Scoping Review

Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-218

Covid-19 -Navigating the Uncharted

Pooled RT-qPCR 227 testing for SARS-CoV-2 surveillance in schools -a cluster randomised trial

Performance of 230 unobserved self-collected nasal swabs for detection of SARS-CoV-2 by RT-PCR 231 utilizing a remote specimen collection strategy

A novel strategy for 234 community screening of SARS-CoV-2 (COVID-19): Sample pooling method

A 237 pooled testing strategy for identifying SARS-CoV-2 at low prevalence

Implementation of an efficient SARS-CoV-2 specimen pooling strategy for high 241 throughput diagnostic testing